Esimerkkejä Pharmacokinetic parameters käytöstä Englanti ja niiden käännökset Suomi
{-}
-
Medicine
-
Colloquial
-
Official
-
Financial
-
Ecclesiastic
-
Official/political
-
Computer
-
Programming
Pharmacokinetic parameters mean%CV.
Mean± SD Saquinavir(%CV) Pharmacokinetic Parameters.
Pharmacokinetic parameters are given in Table 3.
Mean± SD Steady-State Pharmacokinetic Parameters n=24.
Pharmacokinetic Parameters in Caelyx-Treated AIDS-KS.
With the exception of elimination half-life, all pharmacokinetic parameters are dose-dependent.
The pharmacokinetic parameters may be observed in the table below.
Milbemycin oxime plasma concentrations and some pharmacokinetic parameters are increased in the presence of spinosad.
Pharmacokinetic parameters are summarised in the table below.
Based on historical comparisons, methadone did not appear to alter plasma amprenavir pharmacokinetic parameters.
Mean± SD pharmacokinetic parameters of bazedoxifene n=23.
Reception of multiple doses of Lotensin does not affect the pharmacokinetic parameters, does not cause cumulation of benazeprilat.
Pharmacokinetic parameters are presented in Geometric Mean 95% CI.
Elderly In a multivariate analysis, age was not found to be an independent factor of any of the pharmacokinetic parameters studied.
Table 3: Pharmacokinetic parameters of ALPROLIX 50 IU/kg dose.
Population pharmacokinetic analyses of Signifor suggest that race andgender do not influence pharmacokinetic parameters.
The main pharmacokinetic parameters are shown in the following table.
Renal impairment: mild to moderate renal impairment does not significantly affect palonosetron pharmacokinetic parameters.
Pharmacokinetic parameters are comparable to those reported in adults.
At the intended dose, pharmacokinetic parameters are not significantly affected by gender.
Pharmacokinetic parameters of Privigen in PID patients.
Table 10: Mean(± SD)tenofovir pharmacokinetic parameters by age groups for paediatric patients.
Pharmacokinetic parameters of Privigen in 25 PID patients.
Mean(SD) dalbavancin pharmacokinetic parameters using population PK analysis1.
The pharmacokinetic parameters in the second study were comparable.
Paediatric population: The pharmacokinetic parameters of ranolazine have not been studied in the paediatric population< 18 years.
Pharmacokinetic parameters in Caelyx-treated AIDS-KS patients.
Table 4: Pharmacokinetic parameters of Spectrila in 14 children/adolescents.
Pharmacokinetic parameters after 50 IU/kg dose of ELOCTA are presented in Tables 3 and 4.
Linearity Pharmacokinetic parameters of tocilizumab did not change with time.